News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
441,296 Results
Type
Article (22524)
Company Profile (164)
Press Release (418608)
Multimedia
Podcasts (77)
Webinars (13)
Section
Business (135120)
Career Advice (1055)
Deals (24581)
Drug Delivery (106)
Drug Development (53743)
Employer Resources (88)
FDA (10968)
Job Trends (10247)
News (229334)
Policy (20433)
Tag
Academia (1145)
Accelerated approval (3)
Adcomms (17)
Allergies (58)
Alliances (37615)
ALS (59)
Alzheimer's disease (764)
Antibody-drug conjugate (ADC) (99)
Approvals (10989)
Artificial intelligence (238)
Autoimmune disease (18)
Automation (16)
Bankruptcy (210)
Best Places to Work (7888)
BIOSECURE Act (14)
Biosimilars (102)
Biotechnology (79)
Bladder cancer (46)
Brain cancer (20)
Breast cancer (156)
Cancer (1382)
Cardiovascular disease (134)
Career advice (870)
Career pathing (24)
CAR-T (65)
Cell therapy (207)
Cervical cancer (7)
Clinical research (44995)
Collaboration (673)
Compensation (215)
Complete response letters (23)
COVID-19 (1378)
CRISPR (36)
C-suite (192)
Cystic fibrosis (64)
Data (1439)
Decentralized trials (2)
Denatured (19)
Depression (32)
Diabetes (182)
Diagnostics (4026)
Digital health (14)
Diversity (7)
Diversity, equity & inclusion (26)
Drug discovery (89)
Drug pricing (115)
Drug shortages (31)
Duchenne muscular dystrophy (64)
Earnings (49742)
Editorial (34)
Employer branding (10)
Employer resources (81)
Events (63961)
Executive appointments (585)
FDA (11869)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (497)
Gene editing (68)
Generative AI (23)
Gene therapy (187)
GLP-1 (634)
Government (2264)
Grass and pollen (3)
Guidances (44)
Healthcare (10087)
Huntington's disease (14)
IgA nephropathy (23)
Immunology and inflammation (90)
Indications (20)
Infectious disease (1481)
Inflammatory bowel disease (97)
Inflation Reduction Act (8)
Influenza (36)
Intellectual property (67)
Interviews (143)
IPO (10068)
IRA (45)
Job creations (2664)
Job search strategy (765)
Kidney cancer (7)
Labor market (24)
Layoffs (296)
Leadership (21)
Legal (4743)
Liver cancer (34)
Lung cancer (206)
Lymphoma (101)
Machine learning (4)
Management (32)
Manufacturing (274)
MASH (53)
Medical device (7866)
Medtech (7869)
Mergers & acquisitions (14943)
Metabolic disorders (561)
Multiple sclerosis (55)
NASH (20)
Neurodegenerative disease (56)
Neuropsychiatric disorders (24)
Neuroscience (1129)
NextGen: Class of 2025 (4013)
Non-profit (1698)
Now hiring (24)
Obesity (336)
Opinion (205)
Ovarian cancer (39)
Pain (85)
Pancreatic cancer (51)
Parkinson's disease (99)
Partnered (15)
Patents (182)
Patient recruitment (73)
Peanut (27)
People (41019)
Pharmaceutical (79)
Pharmacy benefit managers (21)
Phase I (13998)
Phase II (19014)
Phase III (15375)
Pipeline (889)
Policy (132)
Postmarket research (1718)
Preclinical (5069)
Press Release (43)
Prostate cancer (81)
Psychedelics (18)
Radiopharmaceuticals (187)
Rare diseases (276)
Real estate (4010)
Recruiting (31)
Regulatory (14881)
Reports (26)
Research institute (1202)
Resumes & cover letters (166)
Rett syndrome (3)
RNA editing (2)
RSV (27)
Schizophrenia (63)
Series A (89)
Series B (53)
Service/supplier (13)
Sickle cell disease (39)
Special edition (15)
Spinal muscular atrophy (114)
Sponsored (24)
Startups (2439)
State (2)
Stomach cancer (9)
Supply chain (68)
Tariffs (44)
The Weekly (56)
Vaccines (346)
Venture capitalists (31)
Weight loss (250)
Women's health (24)
Worklife (12)
Date
Today (20)
Last 7 days (558)
Last 30 days (1690)
Last 365 days (21895)
2025 (7334)
2024 (23450)
2023 (26157)
2022 (34489)
2021 (37182)
2020 (36157)
2019 (30393)
2018 (23052)
2017 (22450)
2016 (21223)
2015 (24265)
2014 (18899)
2013 (16084)
2012 (17242)
2011 (17451)
2010 (15659)
Location
Africa (491)
Alabama (32)
Alaska (2)
Arizona (109)
Arkansas (9)
Asia (29812)
Australia (3890)
California (3591)
Canada (1386)
China (394)
Colorado (186)
Connecticut (155)
Delaware (118)
Europe (63827)
Florida (633)
Georgia (147)
Idaho (51)
Illinois (395)
India (24)
Indiana (270)
Iowa (7)
Japan (138)
Kansas (79)
Kentucky (23)
Louisiana (5)
Maine (26)
Maryland (510)
Massachusetts (2798)
Michigan (143)
Minnesota (313)
Mississippi (2)
Missouri (61)
Montana (25)
Nebraska (18)
Nevada (34)
New Hampshire (44)
New Jersey (1277)
New Mexico (25)
New York (996)
North Carolina (712)
North Dakota (8)
Northern California (1511)
Ohio (142)
Oklahoma (8)
Oregon (29)
Pennsylvania (827)
Puerto Rico (12)
Rhode Island (24)
South America (768)
South Carolina (18)
South Dakota (1)
Southern California (1383)
Tennessee (66)
Texas (532)
United States (14606)
Utah (97)
Virginia (120)
Washington D.C. (52)
Washington State (306)
West Virginia (2)
Wisconsin (58)
441,296 Results for "catalent pharma solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
April 28, 2025
·
2 min read
Press Releases
Lisata Therapeutics Announces Research License with Catalent
April 15, 2025
·
7 min read
Press Releases
Catalent Announces New Board Appointments
February 20, 2025
·
4 min read
Editorial
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo Nordisk Foundation, one of the world’s largest charitable foundations.
October 24, 2024
·
6 min read
·
Jef Akst
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Deals
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena
European CDMO Ardena will buy Catalent’s oral solids manufacturing facility in Somerset, N.J.
October 14, 2024
·
1 min read
·
Annalee Armstrong
Editorial
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work
With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.
November 8, 2024
·
4 min read
·
Greg Slabodkin
Mergers & acquisitions
Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition
Now that they’ve received the go-signal from both U.S. and EU anti-trust regulators, Novo Holdings and Catalent expect to wrap up their deal in the coming days.
December 16, 2024
·
2 min read
·
Tristan Manalac
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
Manufacturing
Novo-Catalent Deal Represents ‘Defining Moment’ for CDMO Sector
Novo Holdings’ acquisition of Catalent has ignited concerns from industry stakeholders, who fear that the consolidation could limit competition, but there is also the possibility that the deal could represent an opportunity for smaller-scale CDMOs to find new partners.
November 13, 2024
·
4 min read
·
Ben Hargreaves
1 of 44,130
Next
